Dr. Schroeder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4921 Parkview Pl
Saint Louis, MO 63110Phone+1 314-454-8330Fax+1 314-454-7551- Is this information wrong?
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2006 - 2009
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2003 - 2006
- University of Cincinnati College of MedicineClass of 2003
Certifications & Licensure
- IL State Medical License 2018 - 2026
- MO State Medical License 2006 - 2025
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study for the Evaluation of a GVHD Negative Outcome Score (GNOS) in Matched Unrelated or Haploidentical Hematopoietic Stem Cell Transplant Start of enrollment: 2015 Mar 25
- A Safety Study of SGN-CD352A for Patients With Relapsed/Refractory Multiple Myeloma Start of enrollment: 2016 Dec 01
Publications & Presentations
PubMed
- 2 citationsAcute Graft-versus-Host Disease: An Update on New Treatment Options.Dilan A Patel, Mallory Crain, Iskra Pusic, Mark A Schroeder> ;Drugs. 2023 Jul 1
- 12 citationsMotixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial.Zachary D Crees, Michael P Rettig, Reyka G Jayasinghe, Keith Stockerl-Goldstein, Sarah M Larson, Illes Arpad, Giulio A Milone, Massimo Martino, Patrick Stiff, Douglas ...> ;Nature Medicine. 2023 Apr 1
- 1 citationsA Multicenter Phase 2 Clinical Trial of 10-Day Decitabine, Dose-Escalated Donor Lymphocyte Infusion, and Ruxolitinib for Relapsed Acute Myeloid Leukemia and Myelodyspl...Armin Rashidi, Eric J Huselton, Heather E Stefanski, Todd E DeFor, Ryan Shanley, Jaebok Choi, John F DiPersio, Mark Juckett, Jeffrey S Miller, Daniel J Weisdorf, Mark ...> ;Transplantation and Cellular Therapy. 2023 May 1
- Join now to see all
Journal Articles
- Single Institution Experience with G-CSF Mobilized T-cell Replete Haploidentical Hematopoietic Cell TransplantationM A Schroeder, R Romee, J F DiPersio, T A Fehniger, F Gao, G L Uy, C N Abboud, P Westervelt, R Vij, Nature
Abstracts/Posters
- Updated Study Results of CX-01, an Inhibitor of CXCL12/CXCR4, and Azacitidine for the Treatment of Hypomethylating Agent Refractory AML and MDSClinically Relevant Abst...Mark A. Schroeder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- The Ire of IRE1_: Overexpression of IRE1_ at Myeloma Diagnosis Is Associated with Decreased Survival While Downregulation of IRE1_ Expression Is Predictive of Therapy ...Mark A. Schroeder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Dysregulated Mirnas after Uniform Treatment Predict Outcome of Newly-Diagnosed Multiple MyelomaMark A. Schroeder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
- SYNTHETIC BIOLOGICS, INC. MANAGEMENT's DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (Form 10-Q)August 11th, 2022
- Cellect Biotechnology Initiates U.S. Clinical Trial of ApoGraftOctober 23rd, 2020
- St. Louis: One of the Fastest-Growing Life Sciences MarketsMarch 27th, 2019
- Join now to see all
Hospital Affiliations
- Barnes-Jewish HospitalSaint Louis, Missouri
- Siteman Cancer CenterSaint Louis, Missouri
- Alton Memorial HospitalAlton, Illinois
- Memorial Hospital BellevilleBelleville, Illinois
- Memorial Hospital ShilohO Fallon, Illinois
- Christian HospitalSaint Louis, Missouri
- Barnes-Jewish St. Peters HospitalSaint Peters, Missouri
- Progress West HospitalO Fallon, Missouri
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: